Bayer, Jonas bro urging diabetes care

Share this article:
Bayer Diabetes Care has partnered with Nick Jonas for a campaign urging young people to proactively manage diabetes.

Jonas is a member of music group the Jonas Brothers, and will act as a “diabetes ambassador,” according to a company statement. Jonas was diagnosed with type 1 diabetes at age 13. Jonas uses Bayer's Contour blood/sugar meter, which will be available in green apple, royal purple and graphite gray, “to fit everyone's individual style,” according to the statement.

One component of the partnership is a brand new website—NicksSimpleWins.com—which features a branded discussion with Jonas on diabetes, a Jonas Brothers' song for free download and blogging from Jonas. 

“Nick is a deeply passionate role model for young people with diabetes and their families, and Bayer shares in his dedication,” said Sandra Peterson, president of Bayer Diabetes Care, in the statement. “Bayer believes Nick can play a significant role in encouraging all people with diabetes, no matter how young or old, to be proactive in managing their diabetes to live their lives to the fullest.””  
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?